Matrix HT, Inc. is involved with developing science and technology and procuring personalized medical equipment comprised of novel biosensors for early-stage detection of cancers and viral infections, and novel polymeric nanoparticles for emerging medical technologies of RNA-based therapeutics for advancing the development of mRNA vaccines and RNA drugs. This technology addresses unmet needs and reduces the cost of healthcare and improves patients’ lives around the world.